Univ. Lille, INSERM, CHU Lille, U1189 - ONCO-THAI - Image Assisted Laser Therapy for Oncology, Lille, France.
Department of Dermatology, CHU Lille, Lille, France.
Photodermatol Photoimmunol Photomed. 2019 Jul;35(4):232-237. doi: 10.1111/phpp.12457. Epub 2019 Mar 12.
BACKGROUND/PURPOSE: Photodynamic therapy (PDT) is an established treatment for actinic keratosis (AK). Among the approved protocols in Europe, the most widely used involves irradiation with the Aktilite CL 128 (C-PDT). We aimed to assess the heterogeneity of irradiance over the treatment area when using C-PDT. We also investigated whether there is a cut-off value for protoporphyrin IX (PpIX)-weighted irradiance that may predict the treatment outcome of C-PDT.
An Ophir PD300 photodiode sensor connected to an Ophir Laser Star power meter was used to measure the irradiance delivered to 114 AKs of the scalp and forehead of 19 patients treated with C-PDT. The PpIX-weighted irradiances were deduced and cross-referenced with the complete responses at 3 months.
From the measured irradiances ranging from 0.25 to 60 mW/cm (average: 31.94 mW/cm ), a standard deviation of 17.17 mW/cm was computed. Irradiance heterogeneity over the treatment area during C-PDT was demonstrated. The 66/114 AKs with a complete response at 3 months (57.89%) received a mean PpIX-weighted irradiance of 0.52 mW/cm vs 0.56 mW/cm for the resistant 48/114 AKs (42.11%). No significant effect of PpIX-weighted irradiance on the complete response at 3 months was found (odds ratio for a 0.1-unit change, 0.96; 95% confidence interval, 0.83 to 1.10; P = 0.53). Therefore, no cut-off value for PpIX-weighted irradiance that predicts treatment outcome could be identified.
A device enabling homogeneous irradiation at a lower irradiance than the Aktilite CL 128 may therefore be suitable. This lower irradiance may further increase the treatment tolerance by patients.
背景/目的:光动力疗法(PDT)是一种成熟的光化性角化病(AK)治疗方法。在欧洲批准的方案中,应用最广泛的是 Aktilite CL 128(C-PDT)辐照。我们旨在评估使用 C-PDT 时治疗区域的辐照度异质性。我们还研究了原卟啉 IX(PpIX)加权辐照度是否存在一个截断值,可以预测 C-PDT 的治疗效果。
使用连接到 Ophir Laser Star 功率计的 Ophir PD300 光电二极管传感器,测量 19 例头皮和额部 AK 患者 114 例接受 C-PDT 治疗时的辐照度。推导 PpIX 加权辐照度,并与 3 个月时的完全反应进行交叉参考。
从 0.25 至 60 mW/cm(平均:31.94 mW/cm)的测量辐照度中,计算出 17.17 mW/cm 的标准差。在 C-PDT 期间,治疗区域的辐照度异质性得到了证明。在 3 个月时完全缓解的 66/114 例 AK(57.89%)接受的平均 PpIX 加权辐照度为 0.52 mW/cm,而 48/114 例耐药 AK(42.11%)为 0.56 mW/cm。未发现 PpIX 加权辐照度对 3 个月时完全缓解的显著影响(0.1 单位变化的优势比为 0.96;95%置信区间,0.83 至 1.10;P=0.53)。因此,无法确定预测治疗效果的 PpIX 加权辐照度截断值。
因此,可能适合使用能在低于 Aktilite CL 128 辐照度的情况下实现均匀照射的设备。这种较低的辐照度可能会进一步提高患者的治疗耐受性。